Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matous Hrdinka

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Molecular and Cellular Biology|September 21, 2011
SCIMP, a transmembrane adaptor protein involved in major histocompatibility complex class II signalingPeter Draber, Ivana Vonkova, Ondrej Stepanek, et al.
The EMBO Journal|July 27, 2016
Synaptonuclear messenger PRR7 inhibits c-Jun ubiquitination and regulates NMDA-mediated excitotoxicityDana O Kravchick, Anna Karpova, Matous Hrdinka, et al.
Plos One|September 23, 2016
Normal Development and Function of T Cells in Proline Rich 7 (Prr7) Deficient MiceMatous Hrdinka, Kritika Sudan, Sissy Just, et al.
Cell Reports|March 22, 2016
CYLD Limits Lys63- and Met1-Linked Ubiquitin at Receptor Complexes to Regulate Innate Immune SignalingMatous Hrdinka, Berthe Katrine Fiil, Mattia Zucca, et al.
Nature Communications|November 10, 2022
The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myelomaAlexander Vdovin, Tomas Jelinek, David Zihala, et al.
The EMBO Journal|July 23, 2020
Systematic analysis of the IL-17 receptor signalosome reveals a robust regulatory feedback loopHelena Draberova, Sarka Janusova, Daniela Knizkova, et al.
Molecular Cell|September 4, 2016
SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC SignalingPaul R Elliott, Derek Leske, Matous Hrdinka, et al.
Chemistry & Biology|September 1, 2015
Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase InhibitorsPeter Canning, Qui Ruan, Tobias Schwerd, et al.
The EMBO Journal|July 21, 2018
Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signalingMatous Hrdinka, Lisa Schlicher, Bing Dai, et al.
British Journal of Haematology|October 9, 2023
Insight into the mechanism of CD34<sup>+</sup> cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapyOndrej Venglar, Veronika Kapustova, Anjana Anilkumar Sithara, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Molecular and Cellular Biology|September 21, 2011
SCIMP, a transmembrane adaptor protein involved in major histocompatibility complex class II signalingPeter Draber, Ivana Vonkova, Ondrej Stepanek, et al.
The EMBO Journal|July 27, 2016
Synaptonuclear messenger PRR7 inhibits c-Jun ubiquitination and regulates NMDA-mediated excitotoxicityDana O Kravchick, Anna Karpova, Matous Hrdinka, et al.
Plos One|September 23, 2016
Normal Development and Function of T Cells in Proline Rich 7 (Prr7) Deficient MiceMatous Hrdinka, Kritika Sudan, Sissy Just, et al.
Cell Reports|March 22, 2016
CYLD Limits Lys63- and Met1-Linked Ubiquitin at Receptor Complexes to Regulate Innate Immune SignalingMatous Hrdinka, Berthe Katrine Fiil, Mattia Zucca, et al.
Nature Communications|November 10, 2022
The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myelomaAlexander Vdovin, Tomas Jelinek, David Zihala, et al.
The EMBO Journal|July 23, 2020
Systematic analysis of the IL-17 receptor signalosome reveals a robust regulatory feedback loopHelena Draberova, Sarka Janusova, Daniela Knizkova, et al.
Molecular Cell|September 4, 2016
SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC SignalingPaul R Elliott, Derek Leske, Matous Hrdinka, et al.
Chemistry & Biology|September 1, 2015
Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase InhibitorsPeter Canning, Qui Ruan, Tobias Schwerd, et al.
The EMBO Journal|July 21, 2018
Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signalingMatous Hrdinka, Lisa Schlicher, Bing Dai, et al.
British Journal of Haematology|October 9, 2023
Insight into the mechanism of CD34<sup>+</sup> cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapyOndrej Venglar, Veronika Kapustova, Anjana Anilkumar Sithara, et al.
Pageof 3